| Specialty Retail Industry | Consumer Discretionary Sector | Mark C. Mirken CEO | OTC PINK Exchange | 13767T102 CUSIP |
| US Country | 37 Employees | - Last Dividend | 12 Jun 2014 Last Split | - IPO Date |
CannLabs, Inc. is a pioneering enterprise situated in Denver, Colorado, specializing in comprehensive cannabis testing services across the United States. Since its establishment in 2010, the company has positioned itself as a leader in delivering accurate, reliable testing solutions for cannabis products. With a focus on advancing the safety and understanding of cannabis through science, CannLabs serves a vital role in supporting the industry's regulatory compliance, quality control, and product development efforts.
In addition to these testing services, CannLabs, Inc. also extends its expertise to include data analytics, consulting, and educational services. Through these offerings, CannLabs aims to empower clients with the knowledge and insights needed to navigate the complexities of the cannabis industry successfully.